These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27276221)

  • 1. Strict Selection Alone of Patients Undergoing Liver Transplantation for Hilar Cholangiocarcinoma Is Associated with Improved Survival.
    Mantel HT; Westerkamp AC; Adam R; Bennet WF; Seehofer D; Settmacher U; Sánchez-Bueno F; Fabregat Prous J; Boleslawski E; Friman S; Porte RJ;
    PLoS One; 2016; 11(6):e0156127. PubMed ID: 27276221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation for perihilar cholangiocarcinoma: patient selection and outcomes.
    Acher AW; Weber SM; Pawlik TM
    Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):555-566. PubMed ID: 33577361
    [No Abstract]   [Full Text] [Related]  

  • 3. Liver transplantation for hilar cholangiocarcinoma: A systematic review.
    Machairas N; Kostakis ID; Tsilimigras DI; Prodromidou A; Moris D
    Transplant Rev (Orlando); 2020 Jan; 34(1):100516. PubMed ID: 31711828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant Chemoradiotherapy and Liver Transplantation for Unresectable Hilar Cholangiocarcinoma: The Irish Experience of the Mayo Protocol.
    Zaborowski A; Heneghan HM; Fiore B; Stafford A; Gallagher T; Geoghegan J; Maguire D; Hoti E
    Transplantation; 2020 Oct; 104(10):2097-2104. PubMed ID: 31972704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Con: Liver transplantation for expanded criteria malignant diseases.
    Schaefer B; Zoller H; Schneeberger S
    Liver Transpl; 2018 Jan; 24(1):104-111. PubMed ID: 29125687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of liver transplantation for hilar cholangiocarcinoma.
    Pandey D; Lee KH; Tan KC
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):248-53. PubMed ID: 17548246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modified Jarnagin-Blumgart classification better predicts survival for resectable hilar cholangiocarcinoma.
    Ding G; Yang Y; Cao L; Chen W; Wu Z; Jiang G
    World J Surg Oncol; 2015 Mar; 13():99. PubMed ID: 25889726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended bile duct resection and [corrected] liver and transplantation in patients with hilar cholangiocarcinoma: long-term results.
    Seehofer D; Thelen A; Neumann UP; Veltzke-Schlieker W; Denecke T; Kamphues C; Pratschke J; Jonas S; Neuhaus P
    Liver Transpl; 2009 Nov; 15(11):1499-507. PubMed ID: 19877250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis and Meta-regression of Survival After Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma.
    Cambridge WA; Fairfield C; Powell JJ; Harrison EM; Søreide K; Wigmore SJ; Guest RV
    Ann Surg; 2021 Feb; 273(2):240-250. PubMed ID: 32097164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of liver transplantation for hilar cholangiocarcinoma: A protocol for a systematic review and meta-analysis.
    Cai Z; Yin Y; Cai Z; Zhao Z; Shen C; Yin X; Wang J; Chen Z; Cao D; Zhang B
    Medicine (Baltimore); 2018 Jul; 97(30):e11626. PubMed ID: 30045305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hilar cholangiocarcinoma: expert consensus statement.
    Mansour JC; Aloia TA; Crane CH; Heimbach JK; Nagino M; Vauthey JN
    HPB (Oxford); 2015 Aug; 17(8):691-9. PubMed ID: 26172136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Improved treatment results in hilar cholangiocarcinoma after transition to more extensive procedure: 20 years experience AMC].
    van Gulik TM; Kloek JJ; Ruys AT; Busch OR; van Tienhoven G; Lameris JS; Rauws EA; Gouma DJ
    Ned Tijdschr Geneeskd; 2010; 154():A1815. PubMed ID: 20858305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation for hilar cholangiocarcinoma.
    Thelen A; Neuhaus P
    J Hepatobiliary Pancreat Surg; 2007; 14(5):469-75. PubMed ID: 17909715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
    Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
    World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver Transplant for Perihilar Cholangiocarcinoma (Klatskin Tumor): The Essential Role of Patient Selection.
    Dondorf F; Uteβ F; Fahrner R; Felgendreff P; Ardelt M; Tautenhahn HM; Settmacher U; Rauchfuβ F
    Exp Clin Transplant; 2019 Jun; 17(3):363-369. PubMed ID: 29911960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrahepatic cholangiocarcinoma: indication for transplantation.
    Pascher A; Jonas S; Neuhaus P
    J Hepatobiliary Pancreat Surg; 2003; 10(4):282-7. PubMed ID: 14598146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation for cholangiocarcinoma.
    Schwartz JJ; Hutson WR; Gayowski TJ; Sorensen JB
    Transplantation; 2009 Aug; 88(3):295-8. PubMed ID: 19667927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results following resectional surgery for Klatskin tumors. A twenty-year personal experience.
    Lygidakis NJ; Sgourakis GJ; Dedemadi GV; Vlachos L; Safioleas M
    Hepatogastroenterology; 2001; 48(37):95-101. PubMed ID: 11269010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation for cholangiocarcinoma: selection is essential for acceptable results.
    Friman S; Foss A; Isoniemi H; Olausson M; Höckerstedt K; Yamamoto S; Karlsen TH; Rizell M; Ericzon BG
    Scand J Gastroenterol; 2011 Mar; 46(3):370-5. PubMed ID: 21073376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major hepatectomy in Bismuth types I and II hilar cholangiocarcinoma.
    Xiong J; Nunes QM; Huang W; Wei A; Ke N; Mai G; Liu X; Hu W
    J Surg Res; 2015 Mar; 194(1):194-201. PubMed ID: 25454973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.